Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced the proposed appointment of Mr. Chen Jiehui as an executive director, pending shareholder approval. Mr. Chen brings extensive experience in strategic management and corporate governance, and his appointment is expected to strengthen the company’s leadership and operational capabilities.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$21.70 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products and healthcare services. The company is a significant player in the Chinese market, with a strong emphasis on strategic management, corporate governance, and compliance management.
Average Trading Volume: 1,599,749
Technical Sentiment Signal: Buy
Current Market Cap: HK$45B
For an in-depth examination of 0874 stock, go to TipRanks’ Overview page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money